XTENT Announces Third Quarter 2008 Financi...(istorical facts may be forward-looking ...),Health

Date:11/4/2008

istorical facts may be "forward-looking statements" that involve risks and uncertainties. Specifically, these statements include, but are not limited to those concerning: XTENT's expectations with respect to the timing and amount of any savings that may result from the company's cost reduction initiatives. Forward-looking statements are based on management's current, preliminary expectations, and are subject to risks and uncertainties that could cause actual results to differ from the results predicted and which are included in the "Risk Factors" section of XTENT's most recent quarterly report on Form 10- Q for the quarter ended June 30, 2008. This quarterly report was filed with the SEC on August 12, 2008, and is available on the company's investor relations website at http://www.xtentinc.com and on the SEC's website at http://www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. XTENT undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

XTENT, INC.

(a development stage company)

Condensed Statements of Operations

(unaudited; in thousands, except per share amounts)

Three Months Ended Nine Months Ended

September 30, September 30,

2008 2007 2008 2007

Operating expenses:

Research and development (1) $6,679 $7,767 $25,918 $21,694

General and administrative (1) 2,179 2,632 8,952 7,894

Total operating expenses 8,858
'/>"/>

SOURCE XTENT, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. XTENT Announces Second Quarter 2008 Financial Results and Business Progress
2. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
3. XTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention
4. XTENT to Present at Cowen and Companys 28th Annual Health Care Conference
5. XTENT Announces 2007 Financial Results
6. New study shows extent of harmful human influences on global ecosystems
7. XTENT Announces 2007 Financial Results Conference Call
8. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
9. XTENT Announces Third Quarter 2007 Financial Results
10. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2008 and to Provide a Business Update
11. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008